Future work is aimed at deciphering the contribution of the Hippo pathway, the JAK/STAT pathway and oestrogen signalling, as well as interfering with cells in the microenvironment that modulate tumour progression, such as nerve cells, T cells, macrophages and Nf1+/– stromal cells (Fig. 3). The gene discussed is NF1; the disease is neoplasm.